A detailed history of Covenant Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Covenant Asset Management, LLC holds 24,770 shares of ABBV stock, worth $4.46 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
24,770
Previous 25,740 3.77%
Holding current value
$4.46 Million
Previous $4.41 Million 10.81%
% of portfolio
0.78%
Previous 0.71%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $158,924 - $193,350
-970 Reduced 3.77%
24,770 $4.89 Million
Q2 2024

Aug 02, 2024

SELL
$154.79 - $180.76 $15,014 - $17,533
-97 Reduced 0.38%
25,740 $4.41 Million
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $194,980 - $222,162
1,220 Added 4.96%
25,837 $4.7 Million
Q4 2023

Jan 22, 2024

SELL
$137.6 - $154.97 $174,201 - $196,192
-1,266 Reduced 4.89%
24,617 $3.81 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $10,152 - $11,753
-76 Reduced 0.29%
25,883 $3.86 Million
Q2 2023

Jul 12, 2023

SELL
$132.51 - $164.9 $795 - $989
-6 Reduced 0.02%
25,959 $3.5 Million
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $105,131 - $121,074
727 Added 2.88%
25,965 $4.14 Million
Q4 2022

Jan 24, 2023

BUY
$138.31 - $165.87 $67,910 - $81,442
491 Added 1.98%
25,238 $0
Q3 2022

Nov 03, 2022

BUY
$134.21 - $153.93 $10,065 - $11,544
75 Added 0.3%
24,747 $3.32 Million
Q2 2022

Jul 21, 2022

BUY
$137.62 - $174.96 $32,891 - $41,815
239 Added 0.98%
24,672 $3.78 Million
Q1 2022

Apr 29, 2022

SELL
$131.98 - $163.75 $11,218 - $13,918
-85 Reduced 0.35%
24,433 $3.96 Million
Q4 2021

Jan 26, 2022

SELL
$107.43 - $135.93 $9,990 - $12,641
-93 Reduced 0.38%
24,518 $3.32 Million
Q3 2021

Oct 15, 2021

SELL
$106.4 - $120.78 $29,153 - $33,093
-274 Reduced 1.1%
24,611 $2.66 Million
Q1 2021

Apr 19, 2021

BUY
$102.3 - $112.62 $33,247 - $36,601
325 Added 1.32%
24,885 $2.69 Million
Q4 2020

Jan 28, 2021

BUY
$80.49 - $108.67 $83,307 - $112,473
1,035 Added 4.4%
24,560 $2.63 Million
Q3 2020

Oct 29, 2020

BUY
$85.91 - $100.83 $50,257 - $58,985
585 Added 2.55%
23,525 $2.06 Million
Q2 2020

Jul 24, 2020

BUY
$73.37 - $98.18 $20,763 - $27,784
283 Added 1.25%
22,940 $2.25 Million
Q1 2020

Apr 22, 2020

BUY
$64.5 - $97.79 $80,689 - $122,335
1,251 Added 5.84%
22,657 $1.73 Million
Q4 2019

Jan 24, 2020

SELL
$72.13 - $90.25 $10,098 - $12,635
-140 Reduced 0.65%
21,406 $1.9 Million
Q3 2019

Oct 18, 2019

SELL
$62.98 - $75.72 $15,745 - $18,930
-250 Reduced 1.15%
21,546 $1.63 Million
Q2 2019

Jul 17, 2019

BUY
$65.7 - $83.98 $14,454 - $18,475
220 Added 1.02%
21,796 $1.59 Million
Q1 2019

Apr 26, 2019

SELL
$77.14 - $90.79 $71,123 - $83,708
-922 Reduced 4.1%
21,576 $1.74 Million
Q3 2018

Oct 09, 2018

SELL
$88.91 - $98.84 $44,010 - $48,925
-495 Reduced 2.15%
22,498 $2.13 Million
Q2 2018

Jul 12, 2018

BUY
$89.78 - $106.23 $31,871 - $37,711
355 Added 1.57%
22,993 $2.13 Million
Q1 2018

May 04, 2018

BUY
$92.01 - $123.21 $25,026 - $33,513
272 Added 1.22%
22,638 $2.14 Million
Q4 2017

Jan 12, 2018

BUY
$89.56 - $98.21 $21,763 - $23,865
243 Added 1.1%
22,366 $2.16 Million
Q3 2017

Oct 19, 2017

BUY
$69.85 - $89.22 $1.55 Million - $1.97 Million
22,123
22,123 $1.97 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Covenant Asset Management, LLC Portfolio

Follow Covenant Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Asset Management, LLC with notifications on news.